2014Unpublished venueRequires access

CYP3A4 Basic and Clinical Research Progress

Wei Xiao-don

Open publisher page 1 citations

Abstract

Cytochrome P4503A4(CYP3A4) is a kind of main enzymes exist in human liver and intestinal, accounted for about 25% of the total adult liver CYP450 enzyme. About 50% of the Clinical medicine is through its metabolism, and its gene locus mutation associated with a variety of diseases, the study of CYP3A4 is grinding to a mature, has been gradually clarified the mechanism of interaction between the drug, it can be a variety of drugs competitive inhibition or induction, and affected by certain protein receptors in the regulation and control, can change the pharmacokinetics of drugs, enhance or reduce the effect, caused by individual differences, this also is the important cause of drug interactions. CYP3A4 gene polymorphism and genetic relationship oriented treatment, however, further studies are needed. This paper for CYP3A4 gene polymorphism, distribution and clinical disease and drug review summarizes the current research status.

About this research paper

What this paper is about

Cytochrome P4503A4(CYP3A4) is a kind of main enzymes exist in human liver and intestinal, accounted for about 25% of the total adult liver CYP450 enzyme. About 50% of the Clinical medicine is through its metabolism, and its gene locus mutation associated with a variety of diseases, the study of CYP3A4 is grinding to a mature, has been gradually clarified the mechanism of interaction between the drug, it can be a variety of drugs competitive inhibition or induction, and affected by certain protein receptors in the regulation and control, can change the pharmacokinetics of drugs, enhance or reduce the effect, caused by individual differences, this also is the important cause of drug interactions. CYP3A4 gene polymorphism and genetic relationship oriented treatment, however, further studies are needed. This paper for CYP3A4 gene polymorphism, distribution and clinical disease and drug review summarizes the current research status.

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Cytochrome P4503A4(CYP3A4) is a kind of main enzymes exist in human liver and intestinal, accounted for about 25% of the total adult liver CYP450 enzyme. About 50% of the Clinical medicine is through its metabolism, and its gene locus mutation associated with a variety of diseases, the study of CYP3A4 is grinding to a mature, has been gradually clarified the mechanism of interaction between the drug, it can be a variety of drugs competitive inhibition or induction, and affected by certain protein receptors in the regulation and control, can change the pharmacokinetics of drugs, enhance or reduce the effect, caused by individual differences, this also is the important cause of drug interactions. CYP3A4 gene polymorphism and genetic relationship oriented treatment, however, further studies are needed. This paper for CYP3A4 gene polymorphism, distribution and clinical disease and drug review summarizes the current research status.

Key concepts: CYP3A4, Cytochrome P450, Drug, Biology, Gene, Drug metabolism, Pharmacokinetics, Pharmacology

Related papers

Back to paper searchBrowse research topicsOriginal source
CYP3A4 Basic and Clinical Research Progress — Research Paper | ScholarLens